About POPPY

Preconception to pOst-partum study of cardiometabolic health in Primigravid PregnancY (The POPPY study) aims to understand more about the risks of developing heart disease and diabetes in women who experience placental complications such as pre-eclampsia (high blood pressure and kidney problems), high blood pressure during pregnancy and fetal growth restriction (baby being small). We hope that by understanding this risk we can improve women’s health over their lifetime.

The study is led by the University of Cambridge and involves 7 universities across the UK – Imperial College London, King’s College London, St George’s University of London, University College London, University of Bristol, University of Cambridge and University of Glasgow as well as 7 NHS organisations. 

These are: Addenbrooke’s Hospital (Cambridge), Glasgow Royal Infirmary (Glasgow), St George’s Hospital (London), St Thomas’ Hospital (London), Queen Charlotte’s and Chelsea Hospital (London), University College Hospital (London) and St Mary’s Hospital (Manchester)

The study is funded by Wellcome, a global charitable foundation that supports science and research into urgent health challenges that face the population.

Watch the video below and learn more about POPPY

Participating Sites and Research Teams

King’s College London and St Thomas’ Hospital
St George’s University of London and St George’s Hospital
University College London and University College Hospitals
University of Bristol
University of Cambridge and Addenbrooke’s Hospital
University of Glasgow and Glasgow Royal Infirmary
University of Manchester and St Mary’s Hospital